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Viruses are infectious entities that hijack host replication machineries to produce their 
progeny, resulting, in most cases, in disease and, sometimes, in death in infected host 
organisms. Hosts are equipped with an array of defense mechanisms that span from 
innate to adaptive as well as from humoral to cellular immune responses. We previously 
demonstrated that mouse cells underwent apoptosis in response to influenza virus 
infection. These apoptotic, virus-infected cells were then targeted for engulfment by 
macrophages and neutrophils. We more recently reported similar findings in the fruit 
fly Drosophila melanogaster, which lacks adaptive immunity, after an infection with 
Drosophila C virus. In these experiments, the inhibition of phagocytosis led to severe 
influenza pathologies in mice and early death in Drosophila. Therefore, the induction of 
apoptosis and subsequent phagocytosis of virus-infected cells appear to be an anti-
viral innate immune mechanism that is conserved among multicellular organisms. We 
herein discuss the underlying mechanisms and significance of the apoptosis-dependent 
phagocytosis of virus-infected cells. Investigations on the molecular and cellular features 
responsible for this underrepresented virus–host interaction may provide a promising 
avenue for the discovery of novel substances that are targeted in medical treatments 
against virus-induced intractable diseases.
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iNTRODUCTiON
Viruses are one of the most abundant entities present in the environment. All species, including 
microbial pathogens, such as bacteria and fungi, are subject to infections by viruses (1, 2). Greater 
susceptibility to viral infection has been reported in higher metazoans, such as humans, which 
live in a community system (3). In this system, close interactions exist between species, and, thus, 
infection easily spreads among members of the community (3), particularly under the condition 
of compromised immunity (4). Irrespective of the types of genomes and other structural and 
functional characteristics, viruses behave in a similar manner after invading host organisms. Most 
viruses, if not all, are obligate intracellular parasites and, thus, require immediate access to the 
cytosolic and/or nuclear compartments of host cells (2, 5). In the cytoplasm, viruses hijack the 
FigURe 1 | Similarity in apoptosis-inducing pathways in three model animals. Pathways for the induction of apoptosis in mammals, Drosophila melanogaster, and 
Caenorhabditis elegans are shown. Not all signal mediators are indicated. In the activation of initiator caspases, the mitochondrion is involved in mammals, probably 
involved in Drosophila, and not involved in C. elegans. Initiator caspases are caspase-9 in mammals, caspase-9-like Dronc in Drosophila, and absent in C. elegans, 
while effector caspases are caspase-3 and caspase-7 in mammals, caspase-3-like DrICE and Dcp-1 in Drosophila, and caspase-9-like CED-3 in C. elegans. 
Effector caspases, once activated by initiator caspases, degrade a number of cellular proteins, leading to structural and functional features that are typical of 
apoptosis. In mammals, two different modes of apoptosis-inducing pathways exist, and the so-called intrinsic pathway that involves the action of mitochondria is 
shown. The other one, the extrinsic pathway, which is initiated by extracellular death factors and their receptors independent of mitochondrial actions, is not shown 
(see Figure 4). CED, cell death abnormal; Dcp-1, death caspase-1; DrICE, Drosophila interleukin-1 β-converting enzyme; Dronc, Drosophila Nedd2-like caspase; 
Egl-1, egg-laying defective-1.
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ribosomes of host cells to generate proteins encoded by their 
own genomes for the production of new infective virions (5–8). 
In the nucleus, viruses may utilize, when necessary, host enzymes 
to replicate their genomes and synthesize mRNA. On the other 
hand, host cells are equipped with an array of intracellular and 
extracellular immune responses to limit this viral proliferation 
process (9, 10). The final result of this race between the host and 
virus decides the outcome of infection, from which infected host 
organisms become ill or remain healthy. Although drugs have 
been developed to combat diseases caused by viral infections, 
their efficacy, unlike those against bacteria and fungi, is limited 
to certain types of viruses: targets for effective drugs are nucleo-
side kinases of herpes virus, protease and reverse transcriptase 
of human immunodeficiency virus, neuraminidase of influenza 
virus, and non-structural proteins of hepatitis C virus (11–13). 
Some infectious diseases, such as those caused by Ebola virus 
and highly pathogenic influenza virus, have been challenging 
to treat and often result in a large number of deaths (14–17). 
Therefore, medical treatments that are effective against different 
types of viruses are urgently required.
We herein highlight an underrepresented virus–host interac-
tion, the apoptosis-dependent phagocytosis of virus-infected 
cells, which enables the elimination of viruses as an innate 
immune response. This mechanism may be effective against most 
types of viruses and appears to be conserved among multicellular 
organisms. Therefore, it may provide a better rationale for the 
development of novel medical treatments against virus-induced 
diseases (18, 19).
PHAgOCYTiC eLiMiNATiON OF CeLLS 
UNDeRgOiNg APOPTOTiC DeATH
As one of the host responses evoked upon viral infection, host 
cells are induced to undergo apoptotic death (20, 21). Apoptosis 
is an orchestrated process of self-demolition, which is observed 
across metazoan species and considered to be a major form of 
programmed cell death (22–24). The pathways for the induction 
of apoptosis have been documented for three model animals—
the nematode Caenorhabditis elegans, the fruit fly Drosophila 
melanogaster, and the mouse Mus musculus—and are shown to be 
fundamentally equivalent (22, 25, 26), as illustrated in Figure 1. 
All cellular changes observed during the apoptotic process are 
generally attributed to the actions of cysteine-proteases, caspases, 
FigURe 2 | Processes of apoptosis-dependent phagocytosis. Cells undergoing apoptosis secrete substances that attract phagocytes (STEP 1), often called 
find-me signals, and simultaneously express eat-me signals on their surface (STEP 2). Phagocytes that come into close proximity to apoptotic cells recognize and 
bind eat-me signals using engulfment receptors (STEP 2), and activate signaling pathways for the induction of phagocytosis. The culmination of this signal 
transduction is the generation of pseudopodia that help phagocytes surround and incorporate apoptotic cells (STEP 3). Materials engulfed exist as phagosomes, 
which subsequently fuse with the lysosomes for degradation (STEP 4).
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and the onset of apoptosis involves the activation of initiator 
caspases that, in turn, partially cleave and activate another group 
of caspases, the effector caspase (24, 27, 28). Activated effector 
caspases then cleave a number of cellular proteins, resulting in 
the structural and biochemical features of apoptosis, such as the 
shrinkage of cells, fragmentation of DNA, and condensation of 
chromatin (22).
Apoptotic cells completely disappear: they are engulfed 
and digested by immune cells, a process-dubbed phagocytosis 
(29–31). Phagocytosis was described more than 100 years ago 
through the seminal studies of the late professor Elie Metchnikoff 
(32, 33). Researchers initially investigated the mechanisms 
underlying the phagocytosis of microbial pathogens that invade 
the human body and later identified apoptotic cells as another 
target. The phagocytosis of microbial pathogens is evident in 
innate and adaptive immune responses: phagocytes bind to 
surface structures specific to the target in the former response, 
while immunoglobulin, which binds antigens on the surface of 
pathogens and is often called an opsonin, functions as a ligand 
for an engulfment receptor, i.e., the Fc receptor, of phagocytes 
in the adaptive response. In contrast, antibodies are not 
involved in the phagocytosis of apoptotic cells, and the surface 
structures of the target that undergo modifications during the 
apoptotic process are recognized by the engulfment receptors 
of phagocytes. Under certain conditions, soluble proteins called 
bridging molecules connect apoptotic cells and phagocytes, 
similar to opsonins; however, these bridging molecules do not 
include immunoglobulin. Therefore, apoptotic cell clearance 
is categorized into an innate immune response to eliminate 
cells unwanted by the body. The phagocytic elimination of cells 
undergoing apoptosis is so rapidly accomplished that apoptotic 
cells are rarely detected in tissues and organs. Cells undergoing 
apoptosis maintain the integrity of plasma membrane perme-
ability until engulfment by phagocytes, and thus the noxious 
components of cells do not leak out and damage surrounding 
tissues. Therefore, apoptosis is considered to be a physiological, 
silent mode of cell death (34, 35).
The entire process of the phagocytosis of apoptotic cells is 
shown in Figure 2. Apoptotic cells that are close to engulfment 
release substances, which are often referred to as find-me signals, 
to recruit phagocytes. A number of molecules have been reported 
to act as such signals, including proteins, lipids, and nucleotides, 
and their receptors as well as downstream signal transduction 
pathways have been mostly identified (36–38). Phagocytosis is 
initiated when apoptotic cells are in close proximity to phago-
cytes, which allows engulfment receptors on the surface of 
FigURe 3 | Similarity in signaling pathways for the induction of apoptotic cell clearance in three model animals. Molecules constituting two partly overlapping 
pathways for the induction of phagocytosis in the nematodes, insects, and mammals are shown. The names of eat-me signals, bridging molecules, engulfment 
receptors, and intracellular signal mediators of Caenorhabditis elegans, Drosophila melanogaster, and mammals are shown from left to right with slashes in 
between. All molecules in each individual category are counterparts to each other in three animal species. Refer to the text for explanation.
4
Nainu et al. Phagocytic Elimination of Virus-Infected Cells
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1220
phagocytes to recognize and bind to ligands on the surface of 
target apoptotic cells (34, 35). The ligands for engulfment recep-
tors are called eat-me signals or markers for phagocytosis, which 
appear on the cell surface during the apoptotic process (37, 39, 40). 
The engagement of eat-me signals to the corresponding receptors 
activates signaling pathways that ultimately generate pseudopo-
dia, extensions of plasma membranes that surround and engulf 
target cells (30, 37, 40). Apoptotic cells are then incorporated, 
forming specialized membrane vesicles called phagosomes. 
Phagosomes subsequently fuse with lysosomes, giving rise to 
phagolysosomes (31, 34), and the components of apoptotic 
cells are then subjected to digestion through the actions of 
lysosomal enzymes. There are two partly overlapping pathways 
for the induction of phagocytosis, which are conserved among 
the nematode, fruit fly, and mammals (22, 25, 31, 34), as are 
those for the induction of apoptosis, and are shown in Figure 3. 
In the figure, the names of eat-me signals, engulfment receptors, 
and intracellular signal mediators of C. elegans, Drosophila, and 
mammals are shown. Phosphatidylserine (PS) is an eat-me sig-
nal common among these animal species, and transthyretin-like 
protein 52 (TTR52) in C. elegans and milk fat globule epidermal 
growth factor protein 8 (MFG-E8) in mammals are PS-binding 
proteins that bridge apoptotic cells and phagocytes. The C. elegans 
cell death abnormal protein 1 (CED-1) and its counterparts, 
Draper in Drosophila and multiple epidermal growth factor-like 
domains 10 (MEGF10) in mammals, and integrin INA1-PAT3 of 
C. elegans and its counterparts, αPS3–βν of Drosophila and αv–β3 
and αv–β5 of mammals, are engulfment receptors located at the 
furthest upstream of the two pathways. CED-6 in C. elegans and 
its counterparts, dCed-6 in Drosophila and engulfment adapter 
protein (GULP) in mammals, and CED-2 in C. elegans and its 
counterparts, CT10 regulator of kinase (Crk) in Drosophila, and 
CrkII in mammals, are adaptor proteins that directly bind the 
engulfment receptors upon activation by eat-me signals. The 
C. elegans CED-5 and its counterparts, myoblast city (Mbc) 
of Drosophila and dedicator of cytokinesis 180 (Dock180) of 
mammals, are guanine nucleotide exchange factors that activate 
small G proteins. CED-12 in C. elegans and engulfment and 
cell motility (ELMO) in mammals are another adaptor proteins 
constituting one pathway, but their counterpart in Drosophila, 
dElmo, seems to be dispensable (41). The two pathways con-
verge on the small G proteins CED-10 in C. elegans, Rac1 and 
Rac2 in Drosophila, and Rac1 in mammals, which remodel the 
actin cytoskeleton for the generation of pseudopodia. CED-7 
in C. elegans and its counterparts, CG1718 in Drosophila and 
ATP-binding cassette (ABC) protein A1 in mammals, are ABC 
transporters whose actions in the pathways remain to be solved. 
Some signal mediators remain missing in these pathways and 
need to be identified. Other eat-me signals, bridging molecules, 
engulfment receptors, and signal mediators have been reported, 
which could be incorporated into the pathways shown here or 
constitute additional pathways.
FigURe 4 | Fas and Fas ligand-induced apoptosis in influenza virus-infected 
cells. Upon infection with influenza virus, the production of the death receptor 
Fas and its ligand, the Fas ligand, is enhanced at the level of gene 
transcription. As a result, virus-infected cells have higher levels of Fas and the 
Fas ligand on their surface. When these cells associate with each other, the 
ligand-engaged receptor activates an intracellular signaling pathway for the 
induction of apoptosis. This mode of apoptosis induction is called the 
extrinsic pathway and does not involve mitochondria (see Figure 1).
FigURe 5 | PS-mediated and sugar residue-stimulated phagocytosis of influenza virus-infected cells. Influenza virus-infected cells are induced to undergo apoptosis 
and express PS and viral NA on their surfaces. When phagocytes, macrophages and neutrophils, bind to these cells through interactions between PS and a 
PS-recognizing engulfment receptor, NA enzymatically modifies sugar residues that exist on the surface of phagocytes. The PS-bound receptor activates a signaling 
pathway for the induction of phagocytosis, while modified sugar residues somehow stimulate phagocytosis. NA, neuraminidase; PS, phosphatidylserine.
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iNDUCTiON OF APOPTOSiS AND 
SUBSeQUeNT PHAgOCYTOSiS OF 
iNFLUeNZA viRUS-iNFeCTeD CeLLS
Ranges of cell types, either primarily cultured cells or established 
cell lines, are susceptible to infection with influenza virus and are 
subsequently induced to undergo apoptosis (42–47). Previous 
studies demonstrated that HeLa cells and Madin–Darby canine 
kidney cells become apoptotic upon influenza A virus infection, 
characterized by the cleavage of host chromosomal DNA (48), 
condensation of chromatin (48), surface exposure of PS (49), 
and activation of initiator and effector caspases (50). Further 
studies demonstrated that the initiation of apoptosis in HeLa 
cells infected with influenza H3N2 virus may due to an elevated 
levels of Fas and the Fas ligand, a death receptor and its ligand 
(48, 49, 51). Upon infection, the activity of the transcription fac-
tor CCAAT/enhancer-binding protein β (C/EBPβ) increased, 
possibly through the action of double-stranded RNA-activated 
protein kinase (52), and this factor enhances the transcription 
of Fas- and Fas ligand-encoding genes (51, 53). Influenza virus-
infected cells with elevated levels of Fas and the Fas ligand on the 
cell surface most likely interact with each other for the induc-
tion of apoptosis (54) (Figure 4). Besides the above-described 
study, influenza virus-induced cell death also appears to occur 
through the actions of apoptosis-inducing factor, another cell 
death-inducing ligand, in the human alveolar epithelial cell 
line A549, independent of caspases (55), and the upregulated 
expression of tumor necrosis factor-related apoptosis-inducing 
ligand (TRAIL) and tumor necrosis factor-α was observed in 
human monocyte-derived macrophages exposed to influenza 
H5N1 virus (56). Similarly, the induction of TRAIL was 
reported in natural killer cells, helper T  cells, and cytotoxic 
T cells during infection with influenza H1N1 virus (57). Viral 
clearance was found to be markedly delayed in the presence 
of an anti-TRAIL monoclonal antibody, suggesting an impor-
tant role for TRAIL in the antiviral immune response (57). 
A recent study demonstrated that the upregulated expression of 
B-cell lymphoma-2-associated X protein may be an alternative 
cause of the induction of apoptosis in influenza virus-infected 
cells (58). Nevertheless, all findings revealed that influenza 
virus-infected cells were induced to undergo apoptotic cell death 
(48, 59–61).
Although typical apoptosis mediated by caspases is evident in 
influenza virus-infected cells, virus replication in these cells did 
not appear to be impaired (48). This may be because this type 
of virus rapidly produces its progeny after entering host cells. 
In order to examine the role of apoptosis, we investigated whether 
influenza virus-infected cells are targeted for engulfment by 
phagocytes. The findings obtained from an assay for phagocy-
tosis in vitro using mouse peritoneal macrophages as phagocytes 
showed that HeLa cells became susceptible to phagocytosis 
when infected with influenza A virus (62), and that this leads 
to the inhibition of viral propagation (63). The phagocytosis of 
influenza virus-infected cells appeared to be mediated by PS, the 
eat-me signal characterized in the most detail, and carbohydrate 
moieties on the surface of macrophages, which are modified by 
influenza virus neuraminidase expressed in virus-infected cells 
(62, 64) (Figure 5). Further investigations using an in-vivo model 
of infection in mice revealed the involvement of macrophages 
and neutrophils in the phagocytosis of cells infected with influ-
enza A virus, and this contributed to the mitigation of influenza 
FigURe 6 | Possible mechanism for the induction of apoptosis in Drosophila C virus-infected cells. The process for the propagation of the virus somehow increases 
pro-apoptotic proteins Reaper and Hid, which cause a decrease in the level of DIAP1. This leads to the liberation and, thus, activation of the initiator caspase Dronc 
that partially cleaves the effector caspases DrICE and Dcp-1 for activation. Activated DrICE and Dcp-1, in turn, cleave a number of cellular proteins for apoptotic 
changes. The brownish dot at the end of the viral genome indicates a viral protein called virion protein, genome-linked, which plays a role in the synthesis of viral 
RNA. Dcp-1, death caspase-1; DIAP1, Drosophila inhibitor of apoptosis protein 1; DrICE, Drosophila interleukin-1 β-converting enzyme; Dronc, Drosophila 
Nedd2-like caspase.
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pathologies in mice (65). Find-me signals responsible for the 
recruitment of these phagocytes to the site of virus-infected 
cells remain to be known. The phagocytic activity of alveolar 
macrophages prepared from influenza virus-infected mice was 
stronger than that of macrophages from uninfected counterparts 
(65). Furthermore, the increased mortality of Toll-like receptor 
4-lacking mice infected with influenza virus suggested a role 
for this pattern recognition receptor in antiviral mechanisms 
(65). The rapid mobilization of neutrophils and macrophages to 
target sites soon after influenza virus infection may explain the 
importance of pattern recognition receptors (65). Collectively, 
apoptosis in influenza virus-infected cells makes them susceptible 
to phagocytosis, and this mechanism for the direct elimination of 
the virus serves as an antiviral immune response.
iNDUCTiON OF APOPTOSiS AND 
SUBSeQUeNT PHAgOCYTOSiS OF 
Drosophila C viRUS-iNFeCTeD CeLLS
We then examined whether a similar antiviral mechanism exists 
in insects with no adaptive immunity. We used D. melanogaster 
as a host for infection with Drosophila C virus (DCV), a natural 
pathogen of Drosophila (66, 67). DCV is a non-enveloped, positive-
strand picorna-like RNA virus that belongs to the Dicitroviridae 
genus Cripavirus (66, 68). When S2 cells, a Drosophila culture 
cell line, were incubated with DCV, they underwent apoptosis, as 
was evident from chromatin condensation, DNA fragmentation, 
and caspase activation, accompanied by the propagation of the 
virus (69). We found that the amount of Drosophila inhibitor of 
apoptosis protein 1 (DIAP1), a Drosophila protein that inhibits 
caspases, decreased upon infection with DCV. All these changes 
in S2 cells after viral infection became undetectable when a syn-
thetic inhibitor of caspase was present in cell cultures or the virus 
was pretreated with UV. The mechanisms underlying apoptosis 
in DCV-infected cells have not yet been elucidated; however, 
several studies suggested the involvement of a mechanism 
similar to that observed during the early developmental stages 
of Drosophila (69–71). Upon infection with Flock house virus or 
the DNA virus Autographa californica multicapsid nucleopoly-
hedrovirus, the expression of reaper and head involution defective 
(hid), the products of which antagonize DIAP1, was significantly 
increased in a manner mediated by the transcription control 
regions of the two genes, namely, a p53-bound sequence and 
sequence named the irradiation-responsive enhancer region (71). 
A similar mechanism appears to exist in mosquitoes when they 
are infected with Culex nigripalpus nucleopolyhedrovirus (72). 
We anticipate the following pathway for the induction of apopto-
sis in DCV-infected cells, as shown in Figure 6: the propagation 
of the virus enhances the transcription of reaper and hid; Reaper 
and/or Hid suppress DIAP1; the initiator caspase Drosophila 
Nedd2-like caspase (Dronc) is activated; Dronc cleaves and acti-
vates the effector caspases Drosophila interleukin-1 β-converting 
enzyme (DrICE) and death caspase-1 (Dcp-1); and the activated 
effector caspases degrade cellular proteins.
The presence of l(2)mbn cells, a Drosophila cell line derived 
from larval hemocytes, in cultures of DCV-infected S2 cells 
induced a decrease in the amount of the virus (69). Therefore, 
we examined whether DCV-infected cells are phagocytosed in a 
manner that is dependent on apoptosis and found that this was 
the case. Phagocytosis was partly inhibited in the presence of a 
PS-containing liposome that interferes with the action of this 
phospholipid as an eat-me signal. Drosophila phagocytes used 
the engulfment receptors Draper and integrin αPS3–βν for the 
phagocytosis of apoptotic cells (30), and the inhibited expression 
of either receptor by RNA interference (RNAi) caused a decrease 
in the level of phagocytosis. Phagocytosis was decreased further 
after the simultaneous RNAi of both receptors. These findings 
collectively suggested that DCV-infected cells are subjected to 
apoptosis-dependent phagocytosis by Drosophila phagocytes, 
depending on, at least partly, the eat-me signal PS and engulf-
ment receptors Draper and integrin αPS3–βν. In order to assess 
FigURe 7 | Orchestrated antiviral mechanisms initiated by the phagocytosis of virus-infected cells. Virus-infected cells are subjected to apoptosis-dependent 
phagocytosis, which results in the digestion of viruses together with host cells, Virus Removal. At the same time, phagocytes process incorporated viral proteins for 
the presentation of antigens toward CTLs for their activation, Antigen Presentation. Moreover, phagocytes change the pattern of gene expression at a transcriptional 
level, so that the repertoire of cytokines shifts to the mitigation of inflammation, Inflammation Resolution; the phagocytic activity of phagocytes is enhanced, Trained 
Immunity; and virus-specific RNAi is systemically induced, Trained Immunity. CTLs, cytotoxic T lymphocytes.
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this in vivo, we established a fatal infection of Drosophila adults 
with DCV. The findings of an assay for survivorship revealed 
that Draper and integrin αPS3–βν were both involved in the 
protection of flies from viral infection. Measurements of the viral 
load during infection indicated that these engulfment receptors 
were responsible for reducing viral propagation in adult flies. 
The ectopic expression of a PS-binding protein made flies more 
severely succumb to DCV infection and increased the viral load, 
confirming the PS-mediated phagocytosis of DCV-infected 
cells in adult flies. Hemocytes contained in the adult hemocoel 
appeared to be responsible for the phagocytosis of virus-infected 
cells. These findings indicate that the PS-mediated, Draper and 
integrin αPS3–βν-dependent phagocytosis of DCV-infected, 
apoptotic cells by hemocytes plays a role in antiviral mechanisms 
in Drosophila (see Figure 3).
In Drosophila, RNAi-based antiviral innate immunity has been 
intensely investigated (73–81). Our study now adds another mech-
anism for the immune response, i.e., the apoptosis-dependent, 
phagocytosis-based elimination of virus-infected cells. A recent 
study demonstrated that Drosophila hemocytes spread double-
stranded RNA, which induces virus-specific RNAi, in the entire 
body of adult flies upon viral infection; therefore, cells uninfected 
with the virus acquired the competence for RNAi (82). The 
phagocytosis of virus-infected cells may make hemocytes gain a 
source for the production of double-stranded RNA. More impor-
tantly, the apoptosis-dependent phagocytosis of virus-infected 
cells serves as an antiviral mechanism in Drosophila, which is only 
equipped with innate immunity, indicating that this mechanism 
is an innate immune response against viral infection and com-
mon among multicellular organisms.
CONTRiBUTiON OF APOPTOSiS-
DePeNDeNT PHAgOCYTOSiS  
TO iMMUNiTY CONTROL
Recent studies on the mechanisms and consequences of apoptosis- 
dependent phagocytosis have revealed that this type of phago-
cytosis achieves not only the elimination of unwanted cells but 
also endows additional effects that contribute to the maintenance 
of tissue homeostasis. These effects may cooperatively control, 
with the direct removal of virus-infected cells, immunity to fight 
against viral infection, as shown in Figure 7.
Antigen Presentation
The presentation of antigens by certain types of immune cells 
toward T  lymphocytes is a prerequisite for the induction of 
adaptive immunity. Antigen presentation is mainly accom-
plished by dendritic cells and macrophages, antigen-presenting 
cells (APCs), which sample the peptides of foreign materials, 
such as microbial pathogens, and expose them on the cell surface 
together with the major histocompatibility complex (83–86). 
Although APCs may process the foreign peptides synthesized 
in these cells, the presentation of microbial antigens by APCs 
that are apparently not infected with the corresponding patho-
gens is often observed, and this is an immunological process 
called cross-presentation (84, 87–89). Apoptosis-dependent 
phagocytosis provides a mechanistic basis for this phenomenon; 
APCs that are not infected by the virus engulf virus-infected 
cells undergoing apoptosis, process viral proteins, and present 
viral antigens to cytotoxic T lymphocytes (CTLs) for their acti-
vation (90, 91). Activated CTLs induce apoptosis in cells that 
are infected with the same virus. Therefore, the phagocytosis 
of virus-infected cells may lead to the activation of adaptive 
immune responses.
inflammation Resolution
The phagocytic elimination of cells undergoing apoptotic cell 
death is an immunologically silent reaction; inflammation is not 
evoked. Previous research by Fadok, Henson, and others dem-
onstrated that this mode of phagocytosis more actively resolves 
inflammation (92–95). They showed that macrophages engulf 
apoptotic neutrophils to remove cells that produce and secrete 
pro-inflammatory cytokines, and that neutrophil-engulfing mac-
rophages simultaneously secrete anti-inflammatory cytokines 
such as transforming growth factor-β. Therefore, phagocytes alter 
the repertoire of cytokines after the engulfment of virus-infected 
cells so that possible inflammation ceases in addition to the direct 
elimination of virus.
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Trained immunity
In animals equipped with innate and adaptive immunity, the first 
encounter with foreign substances such as microbial pathogens 
makes the host organism prepare for a second encounter with the 
same substances (96, 97). In the first encounter, the major players 
to combat invaders are the components of innate immunity, and 
they take actions not only to eliminate the invaders but also setup 
the activation of adaptive immunity so that adaptive responses are 
evoked in a rapid and robust manner in the second encounter, a 
mechanism called trained immunity or immunological memory. 
The culmination of trained immunity that involves apoptotic cell 
clearance is expected to be antigen presentation as described above.
Until recently, trained immunity was generally considered to 
not exist in innate immunity, which does not involve antibodies 
and lymphocytes. However, recent studies using Drosophila cast 
doubts on this assumption. Hemocytes, Drosophila macrophages, 
exhibit enhanced phagocytic activity when they encounter targets, 
namely, bacteria (98) and apoptotic cells (41). This is regarded 
as preparation for the next encounter with the same targets in 
order to eliminate them. The enhancement of phagocytic activity 
observed in both studies may have been due to a higher level 
of engulfment receptors. An increase of engulfment receptors 
in phagocytes after phagocytosis was previously reported for 
mammalian macrophages (96, 97), and, thus, trained immunity 
that leads to the activation of phagocytes is most likely conserved 
among multicellular organisms. Our findings also demonstrated 
that gene expression patterns in phagocytes changed after the 
engulfment of apoptotic cells, including the enhanced transcrip-
tion of genes coding for engulfment receptors (41). In addition, 
a change in the mode of cytokine production in macrophages 
appears to occur at the level of transcription (99). Therefore, the 
mode of gene transcription appears to change in phagocytes upon 
the engulfment of apoptotic cells in order to more effectively 
control tissue homeostasis.
CONCLUDiNg ReMARKS
Most living organisms are always exposed to potentially fatal 
infections by viruses and, thus, have acquired several distinct 
mechanisms to prevent the invasion, proliferation, and release of 
viruses. The apoptosis-dependent phagocytosis of virus-infected 
cells is one such mechanism, through which organisms directly 
remove viruses from the body. Cells are induced to undergo 
apoptosis upon infection with a number of viruses, and this pro-
cess inactivates the cellular machineries for gene expression and 
proliferation, which are required by invading viruses to produce 
their progeny in infected cells. Although apoptosis itself retards 
the growth of invaders, virus-infected cells appear to be equipped 
with a more active process, subsequent to apoptosis, for the direct 
elimination of viruses; virus-infected cells become susceptible to 
phagocytosis for degradation. Recent studies demonstrated that 
not only apoptotic cells, but also those undergoing other types 
of cell death are subjected to phagocytic elimination (100–102). 
Nevertheless, apoptosis remains a major biological process for 
the safe removal of cells unwanted by the body because it is 
the only mode of cell death during which the control of plasma 
membrane permeability is maintained. As opposed to viruses, 
Leishmania major, an intracellular parasite, appears to exploit the 
mechanisms described above for the establishment and dissemi-
nation of infection (103). Upon entry into animals, these types 
of protozoa are first captured by neutrophils that subsequently 
undergo apoptosis. Then, L. major-infected, apoptotic neutro-
phils are phagocytosed by macrophages, which are primary host 
cells for these protozoa. The pathogens survive and replicate in 
macrophages, and, at the same time, macrophages create an anti-
inflammatory environment. As a result, L. major disseminates its 
infection. The mechanisms by which L. major evades killing and 
digestion in neutrophils and macrophages remain to be clarified.
Individual processes that constitute the apoptosis-dependent 
phagocytosis of virus-infected cells may be targeted by the 
development of novel medical treatments against virus-induced 
diseases. The enhancement of apoptosis in virus-infected cells 
may be one such treatment. Apoptosis is induced in cells that 
ideally need to be retained, and, thus, this treatment needs to be 
restricted to cells infected with viruses. In order to achieve this, 
the mechanisms underlying virus-induced apoptosis need to be 
elucidated in more detail. Another concern is the presence of 
proteins that inhibit apoptosis by antagonizing caspases in some 
types of viruses, particularly DNA viruses (20, 21, 104). The devel-
opment of a method to repress apoptosis-inhibiting viral proteins 
may be an effective treatment. On the other hand, molecules 
involved in the process of the phagocytosis of virus-infected cells 
have been largely identified, and the stimulation of phagocytic 
activity is not always harmful to health. A substance that acts 
as an agonist for engulfment receptors is a promising candidate 
for an effective drug. Alternatively, the secondary effects of the 
phagocytosis of apoptotic cells may be targeted. The administra-
tion of apoptotic cells to patients may contribute to mitigating 
inflammation and stimulating phagocytes, and antiviral adap-
tive immunity is expected when apoptotic cells harboring viral 
antigens are used to treat patients. However, such efforts toward 
inventing novel medical treatments require great care, because 
the apoptosis-dependent phagocytosis of microbe-infected cells 
could favor the pathogens, as an example shown above.
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